Bisphosphonates, dental care and osteonecrosis of the jaws
Sitters, M.A.; Caldwell, C.S.
Texas Dental Journal 122(9): 968-972
2005
ISSN/ISBN: 0040-4284 PMID: 16320504 Document Number: 594231
Document emailed within 1 workday
Related Documents
Urade, M. 2007: Bisphosphonates and osteonecrosis of the jaws Clinical Calcium 17(2): 241-248Urade, M. 2010: Bisphosphonates (BP) and osteonecrosis of the jaws; should administration of BP be discontinued at the early phase? Clinical Calcium 20(11): 1740-1743
Agrillo, A.; Nastro Siniscalchi, E.; Facchini, A.; Filiaci, F.; Ungari, C. 2012: Osteonecrosis of the jaws in patients assuming bisphosphonates and sunitinib: two case reports European Review for Medical and Pharmacological Sciences 16(7): 952-957
Alloh Amichia, Y.C.; Le Bars, P.; Giumelli, B.; Soueidan, A. 2010: Prosthetic rehabilitation after osteonecrosis of the jaws due to histiocytosis X and treatment with bisphosphonates apropos of a case Odonto-Stomatologie Tropicale 33(132): 34-40
Oltolina, A.; Achilli, A.; Lodi, G.; Demarosi, F.; Sardella, A. 2005: Osteonecrosis of the jaws in patients treated with bisphosphonates. Review of the literature and the Milan experience Minerva Stomatologica 54(7-8): 441-448
Sarzi Amadè, D.; Tallarico, M.; Loreti, M.C.; Montecchi, P.P.; Niccoli, A. 2008: Clinical guidelines for prevention of osteonecrosis of the jaws in patients in treatment with bisphosphonates: literature review and report of three cases Minerva Stomatologica 57(9): 429-446
Sambrook, P.; Olver, I.; Goss, A. 2006: Bisphosphonates and osteonecrosis of the jaw Australian Family Physician 35(10): 801-803
Doogue, M. 2006: Bisphosphonates, osteonecrosis of the jaw, and pharmacovigilance New Zealand Medical Journal 119(1246): U2334
Finkelshteyn, A.; Yarom, N. 2017: Drug-induced osteonecrosis of the jaw - not just bisphosphonates Refu'at Ha-Peh Veha-Shinayim 34(1): 32-35; 72
Bolland, M.; Hay, D.; Grey, A.; Reid, I.; Cundy, T. 2006: Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective New Zealand Medical Journal 119(1246): U2339
Machálka, M. 2006: Osteonecrosis of the jaw following complex tumour treatment using bisphosphonates Vnitrni Lekarstvi 52(Suppl 2): 79; 81-82
DE Iuliis, F.; Taglieri, L.; Amoroso, L.; Vendittozzi, S.; Blasi, L.; Salerno, G.; Lanza, R.; Scarpa, S. 2014: Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates Anticancer Research 34(5): 2477-2480
Kraj, M.; Pogłód, R.; Maj, S.ła.; Owczarska, K. 2006: The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates Acta Poloniae Pharmaceutica 63(5): 450-452
Dehari, H.; Tomihara, K.; Ueda, M.; Shimanishi, M.; Ono, M.; Sasaki, T.; Igarashi, T.; Shiratori, K.; Abe, M.; Ogi, K.; Nakamori, K.; Miyazaki, A.; Nagai, I.; Hiratsuka, H. 2009: Clinical investigation of bisphosphonate-related osteonecrosis of the jaws Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(13): 2587-2592
Kamoh, A.K.; Ogle, O. 2012: Bisphosphonate-related osteonecrosis of the jaws--a case report Compendium of Continuing Education in Dentistry 33(5): E74-E77
Pongchaiyakul, C.; Auraiwan, K.; Kotruchin, P.; Kularbkaew, C. 2007: Bisphosphonate-related osteonecrosis of the jaws (ONJ): a report of two cases Journal of the Medical Association of Thailand 90(11): 2494-2498
Ishikawa, T. 2014: A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(2): 225-227
Parisuthiman, D. 2007: Bisphosphonate-related osteonecrosis of the jaws: a call for multidisciplinary approaches Journal of the Medical Association of Thailand 90(12): 2699-2708
Etminan, M.; Aminzadeh, K.; Matthew, I.R.; Brophy, J.M. 2008: Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study Journal of Rheumatology 35(4): 691-695
Dimopoulos, M.A.; Kastritis, E.; Anagnostopoulos, A.; Melakopoulos, I.; Gika, D.; Moulopoulos, L.A.; Bamia, C.; Terpos, E.; Tsionos, K.; Bamias, A. 2006: Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid Haematologica 91(7): 968-971